| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.16 | 0.4 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.15 | 0.4 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.4 |